ReviewRadiologie (Heidelberg, Germany)2022
[Spectral computed tomography in the age of photon-counting X-ray detectors].
Review in Radiologie (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [CT technology: photon-counting detector computed tomography].Radiologie (Heidelberg, Germany) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince its introduction, spectral computed tomography has become an integral part of clinical imaging with a variety of possible applications. Over time, technical innovations have considerably improved the spatial and energy resolution. The recent introduction of computed tomographs utilizing photon-counting x‑ray detectors has opened up further applications, which need to be investigated regarding their clinical utility.
objectivesThis article gives an overview of the development of spectral computed tomography in general and photon-counting computed tomography in particular, with a special focus on recent technical developments and their clinical applications.
conclusionVery likely, photon-counting X‑ray detectors will over time prevail over conventional energy-integrating detectors. Most technical problems hindering clinical use have been overcome, so that the unquestionable advantages outweigh the remaining disadvantages. Further developments especially of detector electronics, reconstruction algorithms and software-based postprocessing will further support its clinical introduction.
Indexed as
Identifiers
35925058What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.